Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Liver Int. 2011 Nov 22;32(4):665–674. doi: 10.1111/j.1478-3231.2011.02686.x

Table 4.

Risk of histological fibrosis progression by YKL-40 promoter polymorphism at rs4950928

All patients (n=209) With fibrosis progression (n=70) Without fibrosis progression (n=139) Hazard ratio (95% CI) * p-value
Homozygous major (CC) 138 (72.3%) 49 (75.4%) 89 (70.6%) 1 Ref 0.64
Heterozygous (CT) 50 (26.2%) 14 (21.5%) 36 (28.6%) 0.88 (0.53, 1.48)*
Homozygous minor (TT) 3 (1.6%) 2 (3.1%) 1 (<1%)
Missing rs4950928 18 5 13
*

Hazard ratio calculated assuming an additive model to compare the 3 genotype groups.